265 related articles for article (PubMed ID: 22067331)
1. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
2. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas.
Miettinen M; Sarlomo-Rikala M; Wang ZF
Am J Surg Pathol; 2011 Dec; 35(12):1848-56. PubMed ID: 21959309
[TBL] [Abstract][Full Text] [Related]
3. Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma.
Le Huu AR; Jokinen CH; Rubin BP; Mihm MC; Weiss SW; North PE; Dadras SS
Am J Surg Pathol; 2010 Nov; 34(11):1563-73. PubMed ID: 20975337
[TBL] [Abstract][Full Text] [Related]
4. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF
Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
[TBL] [Abstract][Full Text] [Related]
7. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
8. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
10. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.
Miettinen M; Wang ZF; Paetau A; Tan SH; Dobi A; Srivastava S; Sesterhenn I
Am J Surg Pathol; 2011 Mar; 35(3):432-41. PubMed ID: 21317715
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate receptor 1 is a useful adjunct for distinguishing vascular neoplasms from morphological mimics.
Akiyama T; Hamazaki S; Monobe Y; Nishimura H; Irei I; Sadahira Y
Virchows Arch; 2009 Feb; 454(2):217-22. PubMed ID: 19005676
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
13. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
Miettinen M; Sarlomo-Rikala M; Lasota J
Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
[TBL] [Abstract][Full Text] [Related]
14. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
15. ERG expression in epithelioid sarcoma: a diagnostic pitfall.
Miettinen M; Wang Z; Sarlomo-Rikala M; Abdullaev Z; Pack SD; Fetsch JF
Am J Surg Pathol; 2013 Oct; 37(10):1580-5. PubMed ID: 23774169
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver.
Fujii T; Zen Y; Sato Y; Sasaki M; Enomae M; Minato H; Masuda S; Uehara T; Katsuyama T; Nakanuma Y
Mod Pathol; 2008 Feb; 21(2):125-30. PubMed ID: 18084256
[TBL] [Abstract][Full Text] [Related]
17. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody.
Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP
Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993
[TBL] [Abstract][Full Text] [Related]
18. β-Adrenergic receptor expression in vascular tumors.
Chisholm KM; Chang KW; Truong MT; Kwok S; West RB; Heerema-McKenney AE
Mod Pathol; 2012 Nov; 25(11):1446-51. PubMed ID: 22743651
[TBL] [Abstract][Full Text] [Related]
19. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
20. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
Fukunaga M
Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
